Thymidine kinase gene transfer by herpes simplex virus
- PMID: 187268
Thymidine kinase gene transfer by herpes simplex virus
Abstract
The current state of knowledge concerning the biochemical transformation by Herpes Simplex virus (HSV) of mammalian cells lacking the enzyme thymidine kinase (TK) is reviewed. Transformation of thymidine kinase negative mouse cells (LTK-) to the TK+ phenotype by ultraviolet light-inactivated HSV preparations depends both on the irradiation dose and on the multiplicity of infection. Once stably associated with the transformed cell, the HSV thymidine kinase appears to be regulated differently than the cellular enzyme: HSV TK activity is maximal in stationary cells, whereas cellular TK activity is maximal during the S-pphase of growing cells. Furthermore, infection with an HSV TK- mutant virus leads to the induction of TK activity in HSV TK+ cells, but not in normal TK+ cells. Recent studies indicate that in addition to the TK gene, at least one other HSV gene, perhaps a structural antigen of the virion, is also transferred to TK- cells. This is consistent with the finding that a clone of HSV TK+ cells harbors approximately five copies per cell of 23 per cent of the HSV genome.
Similar articles
-
[Genetic transformation of somatic cells. VI. Transfer of the trait of the rate of loss of transformant phenotype by means of DNA from cells containing the thymidine kinase gene of the herpes simplex virus].Tsitologiia. 1985 Jun;27(6):678-87. Tsitologiia. 1985. PMID: 2992137 Russian.
-
Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.Mol Pharmacol. 1987 Sep;32(3):410-6. Mol Pharmacol. 1987. PMID: 2823092
-
Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.J Gen Virol. 1983 Sep;64 (Pt 9):1999-2006. doi: 10.1099/0022-1317-64-9-1999. J Gen Virol. 1983. PMID: 6193244
-
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.Cancer Res. 2001 Apr 1;61(7):2983-95. Cancer Res. 2001. PMID: 11306477
-
Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.Cancer Gene Ther. 1996 Mar-Apr;3(2):99-106. Cancer Gene Ther. 1996. PMID: 8729908